Navigation Links
Reassuring evidence: Anticancer drug does not accelerate tumor growth after treatment ends
Date:2/7/2013

Studies in animals have raised concerns that tumors may grow faster after the anticancer drug sunitinib is discontinued. But oncologists and physicists who collaborated to analyze data from the largest study of patients with kidney cancer convincingly demonstrate that such tumor acceleration does not occur in humans. The findings, publishing online on February 7th in the Cell Press journal Cell Reports, suggest that sunitinib does not cause lingering risks for patients after their treatment ends.

"We were able to demonstrate that this applied across all patients and that those who had the greatest benefit from the drug while it was administered retained this benefit," says senior author Dr. Tito Fojo, of the National Cancer Institute at the National Institutes of Health.

Sunitinib, which is approved around the world for the treatment of several different cancers, works by targeting proteins on the blood vessels that feed tumors. Animal studies have suggested that treatment with sunitinib may induce changes in tumor vessels or adaptations within tumors themselves that could promote cancer growth and spread.

When Dr. Fojo and his colleagues analyzed more than 10,000 data points from the pivotal randomized phase 3 clinical trial that led to sunitinib's approval, the evidence clearly showed that no matter how long patients took sunitinib, it was not harmful, did not accelerate tumor growth, and did not shorten survival after treatment ended. During treatment, the drug slowed tumor growth and prolonged the patients' survival.

"Last year, I was approached by two patients who had grave concerns about taking sunitinib due to an article conducted in animals. I realized that if clinical data exist that refute basic science, they must be published," recalls Dr. Fojo.

The researchers' findings indicate that sunitinib can benefit patients without altering tumor biology after the drug is stopped. "We hope this can be ge
'/>"/>

Contact: Mary Beth OLeary
moleary@cell.com
617-397-2802
Cell Press
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Potential new technique for anticancer radiotherapy could provide alternative to brachytherapy
2. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
3. Enzyme accelerates malignant stem cell cloning in chronic myeloid leukemia
4. Fat Loss 4 Idiots: Review Examining New "Accelerated Fat Loss Diet" Released By DietsAndFitnessGuides.com
5. EzW2 Software From Halfpricesoft.com Updated To Accelerate Tax Reporting For Startups
6. Studying marrow, URMC researchers accelerate blood stem cells
7. Topical simvastatin shown to accelerate wound healing in diabetes
8. Concussions and head impacts may accelerate brain aging
9. Accelerated resolution therapy significantly reduces PTSD symptoms, researchers report
10. Higher energies for laser-accelerated particles possible
11. Accelerated radiation treatment effective for noninvasive breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Reassuring evidence: Anticancer drug does not accelerate tumor growth after treatment ends
(Date:7/25/2014)... The North America Artificial lift market report ... with analysis and forecast of revenue. The artificial lift market ... billion in 2013 to around $7 billion by 2018, at ... Browse through the TOC of North America artificial lift market ... also provides a glimpse of the segmentation in North America ...
(Date:7/25/2014)... Agoura Hills dentist , Dr. Amir ... Zoom Whitening is one of the most powerful whitening treatments ... professional. This light-assisted treatment uses a prescription-strength gel that can ... to break up stains that are in both the enamel ... soft drink and tobacco stains. , About Dr. Amir ...
(Date:7/25/2014)... July 25, 2014 The rising pharmaceutical sale ... to the growth of the US PBM industry. A slow ... value of pharmaceutical sales in the US over the past ... attributed to rise in the prescription volume over the past ... Benefit Management (PBM): 2013 Edition” the demand for the pharmacy ...
(Date:7/25/2014)... 25, 2014 Ross A. Clevens, MD, ... invited to join the exclusive Obagi Clinical Advisory Board, ... plastic surgeons, plastic surgeons and dermatologists. , Dr. ... Advisory Board of thought leaders held its first meeting ... was to give Obagi the opportunity to meet with ...
(Date:7/25/2014)... FRIDAY, July 25, 2014 (HealthDay News) -- Dietary changes ... gut on a daily basis, according to a new ... systems that might help detect and ease flare-ups for ... disease (ulcerative colitis and Crohn,s disease), the researchers said. ... but their effect on human health isn,t well understood, ...
Breaking Medicine News(10 mins):Health News:North America Artificial Lift Services Market is Expected to Reach $7 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Artificial Lift Services Market is Expected to Reach $7 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Artificial Lift Services Market is Expected to Reach $7 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Agoura Hills Dentist, Dr. Amir Choroomi, is Now Offering a Promotion on Zoom Whitening 2Health News:US Pharmacy Benefit Management (PBM) Market Trends and Developments Now Available at MarketReportsOnline.com 2Health News:US Pharmacy Benefit Management (PBM) Market Trends and Developments Now Available at MarketReportsOnline.com 3Health News:Renowned Melbourne Plastic Surgeon to Join Private Medical Advisory Board 2Health News:Diet Changes Can Alter Gut Bacteria, Study Says 2
... 10 The Community Oncology Alliance (COA) today issued a ... their practices if critical Medicare reimbursement fixes for treating cancer ... reform. , "Current health reform legislation before Congress does not ... in January to cancer care," said Patrick Cobb, ...
... , SACRAMENTO, Calif., Dec. 10 ... California Affiliates of Susan G. Komen for the Cure® signaled ... Every Woman Counts program, which would effectively shut ... low-income and uninsured women for the first six months of ...
... A never-approved drug developed to prevent the death of nerve ... keeping normal cells healthy and intact, an international team led ... journal Breast Cancer Research . Prof. Malka ... stroke drug a member of a family of phenanthridine ...
... ... Laser-type device to be ... San Diego (PRWEB) ... jointly entered into a letter of intent with Advanced Light Devices to develop a proprietary laser system. It ...
... , SILVER SPRING, Md., Dec. 10 The U.S. ... approved to replace a portion of plasma used when storing ... donor plasma to be used for other purposes. , (Logo: ... platelets, which are blood components that help with blood clotting, ...
... SALEM, Ore., Dec. 10 West Coast Bank,s Salem Battle Creek ... hospitalized at the Salem Hospital Pediatric Wing and Neonatal Intensive Care ... branch, 5686 Commercial St. SE, Suite 110 on week days from ... Manager of Pediatrics at Salem Hospital said, "The hospital is in ...
Cached Medicine News:Health News:National Oncologist Group Warns: Current Health Care Reform Legislation Woefully Short in Addressing Cancer Care Crisis 2Health News:National Oncologist Group Warns: Current Health Care Reform Legislation Woefully Short in Addressing Cancer Care Crisis 3Health News:National Oncologist Group Warns: Current Health Care Reform Legislation Woefully Short in Addressing Cancer Care Crisis 4Health News:California Breast Cancer Survivors and Advocates Call on State to Nix Screening Cuts 2Health News:California Breast Cancer Survivors and Advocates Call on State to Nix Screening Cuts 3Health News:Finding the Achilles' heel of cancer 2Health News:Entest BioMedical Enters into LOI with Advanced Light Devices to Develop Laser Platform for Stem Cell / Laser COPD Treatment 2Health News:Entest BioMedical Enters into LOI with Advanced Light Devices to Develop Laser Platform for Stem Cell / Laser COPD Treatment 3Health News:FDA Approves First Additive Solution for Platelet Storage Up to 5 Days 2
(Date:7/24/2014)... , July 24, 2014   AcelRx Pharmaceuticals, Inc. ... focused on the development and commercialization of innovative therapies ... confirmed the PDUFA date for Zalviso remains July 27, ... rumor circulated online stating the Food and Drug Administration ... there has been no notification to the company from ...
(Date:7/24/2014)... , July 24, 2014  Restore Health, ... and compounded pharmaceuticals, announced that it is now ... unique to each individual based upon their particular ... by understanding the interaction between a patient,s genetics ... "We,re very excited to provide this new service ...
(Date:7/24/2014)... 24, 2014  Uroplasty, Inc. (NASDAQ: UPI ... and markets innovative proprietary products to treat voiding ... 2015 first quarter ended June 30, 2014.  ... Neuromodulation System grew 19% to $4.1 million, as ... of the prior year.  Total revenue for the ...
Breaking Medicine Technology:AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11
... Feb. 24, 2011 Reportlinker.com announces that a ... catalogue: Global Computer Assisted ... http://www.reportlinker.com/p0397748/Global-Computer-Assisted-Surgical-CAS-Systems-Industry.html This report analyzes ... Systems in US$ Million by the following Product ...
... Reportlinker.com announces that a new market research report is ... Drug-Eluting Stents Industry http://www.reportlinker.com/p080457/Global-Drug-Eluting-Stents-Industry.html ... for Drug-Eluting Stents in US$ Million. The report provides ... Rest of World. Annual estimates and forecasts are provided ...
Cached Medicine Technology:Reportlinker Adds Global Computer Assisted Surgical (CAS) Systems Industry 2Reportlinker Adds Global Drug-Eluting Stents Industry 2
QC 123 is an assayed quality control material for blood gas instrumentation. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
For the qualitative detection of Infectious mononucleosis IgM heterophile antibodies in human whole blood, serum and plasma specimens....
For the qualitative detection of luteinising Hormone (LH) in urine specimens...
For the qualitative detection of group A Streptococcal antigen from throat swabs...
Medicine Products: